An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers	Advanced Cancer; Advanced Malignancies	Recruiting	Phase 1	2026-09-25		NCT07426757

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Pfizer	431

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Arthur J.E. Child Comprehensive Cancer Centre	Calgary	Canada	45
Colorado Blood Cancer Institute	Denver	United States	178
Emory University Hospital	Atlanta	United States	131
Emory University Hospital Midtown	Atlanta	United States	246
Presbyterian/St. Luke's Medical Center	Denver	United States	3
Sarah Cannon Research Institute - Pharmacy	Nashville	United States	8
Scri Oncology Partners	Nashville	United States	156
Sylvester Comprehensive Cancer Center	Miami	United States	37
Sylvester Comprehensive Cancer Center - Coral Springs	Coral Springs	United States	4
Sylvester Comprehensive Cancer Center - Hollywood	Hollywood	United States	5
Sylvester Comprehensive Cancer Center - Plantation	Plantation	United States	5
Sylvester Comprehensive Cancer Center - Sole Mia	North Miami	United States	2
Sylvester Comprehensive Cancer Center- Doral	Doral	United States	4
Sylvester Comprehensive Cancer Center- Kendall	Miami	United States	2
Sylvester Comprehensive Cancer Center- The Lennar Foundation Medical Center	Coral Gables	United States	4
Tristar BMT	Nashville	United States	5
TriStar Centennial Medical Center	Nashville	United States	23
University Health Network- Princess Margaret Cancer Centre	Toronto	Canada	1
University of Miami Hospital and Clinics	Miami	United States	20
University of Miami Hospital and Clinics - Deerfield Beach	Deerfield Beach	United States	7
Winship Cancer Institute, Emory University	Atlanta	United States	47

Clinical trials